ArticleFrontiers in neurology2025
Analysis of clinical features and genetic variants in Chinese children with pyridoxine-dependent epilepsy: a case series study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To summarize the clinical features and the spectrum of Methods: Clinical data were collected from six pediatric patients with PDE treated at Linyi People's Hospital (2017-2023). Whole-exome sequencing, in conjunction with Sanger sequencing, was used to screen for Results: In six cases of PDE, the male-to-female ratio was 2:4. Five cases began in the neonatal period, and one in early infancy. Three cases experienced hypoxiaetal distress or respiratory distress. Two cases had a family history of recurrent miscarriages or premature deaths of siblings due to seizures. Seizure types varied among the cases. Three individuals experienced cluster seizures, two were heat-sensitive, and four suffered from status epilepticus. Video EEGs of four children revealed hypsarrhythmia, focal, or multifocal discharges initially, which normalized within 3 days to 8 months following vitamin B6 treatment. All patients initiated regular vitamin B6 therapy between 32 days and 17 months post-onset, with an initial dose ranging from 7.7 to 12.5 mg/(kg·d). During follow-up until the age of 1 to 8 years, the maintenance dose was adjusted to 3.3-7.8 mg/(kg·d). Two patients who began standardized treatment before the age of 3 months experienced normal development. The remaining patients showed mild to moderate developmental delays. Eight variants were identified, including a hotspot in Chinese children: c.1008+1G>A, and two recurrent sites: c.1061A>G and c.1547A>G. Additionally, three variants were novel. Conclusion: Pyridoxine-dependent epilepsy must be distinguished from hypoxic-ischemic encephalopathy and other thermally sensitive epilepsies. The severity of the condition and neurodevelopmental outcomes in affected children vary significantly. Early administration of low-dose pyridoxine can effectively control seizures and reverse EEG abnormalities, potentially improving long-term neurodevelopmental outcomes. c.1061A>G and c.1547A>G may be hotspot variants in Chinese children with PDE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.